Company intelligence
Global Allergy & Airways Patient Platform
Empowering patients with allergies, airways, and atopic diseases around the world.
About Global Allergy & Airways Patient Platform
GAAPP Mission: To globally support and empower patients with allergies, airways and atopic diseases by protecting their rights and insisting on the duties of governments, healthcare professionals and the general public. GAAPP Objectives: To establish a global network to empower patients with allergies, airways and atopic diseases by: - Working together with governmental and health-care organizations to minimize the impact of allergies, asthma, COPD, atopic dermatitis and urticaria - Being an equal partner involved in the decision-making from inception to conclusion with global health-care organizations - Facilitating the founding of patient organizations in emerging countries fighting for best-practice therapy To support the worldwide community managing allergies, airways and atopic diseases by: - Assisting patients to take an active role in managing their disease and empowering those who support them in the process - Demanding unpolluted healthy air for patients - Collaborating with member organizations to help with health and social policy concerns -Aid emerging countries with the necessary diagnostic and therapeutic remedies for patients
Verified activity
Signals from Global Allergy & Airways Patient Platform
11 published signals
Presence & Recognition
Global Allergy & Airways Patient Platform announced that Vildana Mujkic will speak tomorrow on the anaphylaxis patient perspective at the European Parliament.
Reported by Global Allergy & Airways Patient Platform
Presence & Recognition
Global Allergy & Airways Patient Platform joined World Patients Alliance to amplify World Patient Safety Day 2026.
Reported by Global Allergy & Airways Patient Platform
Presence & Recognition
Global Allergy & Airways Patient Platform presented at ICAN IV 2026 in Barcelona, covering topics on precision respiratory medicine, COPD, bronchiectasis, and PCD.
Reported by Global Allergy & Airways Patient Platform